Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...

An interesting option might be the combination of two or more tumor markers in order to improve sensitivity as has been reported recently. [29] In colorectal cancer, Tumor M2-PK proves to be an ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Exploring the link between liver cirrhosis and liver metastasis in colorectal cancer. Systematic literature review (SLR) of prognostic factors (PFs) in locally advanced rectal cancer (LARC) and ...

CAFs, cancer-associated fibroblasts; CAR-T, chimeric antigen receptor-T; CRC, colorectal cancer; ECM, extracellular matrix; MDSCs, myeloid-derived suppressor cells; TAMs, tumor-associated macrophages; ...

A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release ...

In order to increase awareness of the need of identifying symptoms and promptly seeking medical assistance, Radwah Oda discusses her experience of failing to recognize early signs of stage 4 colon ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

Colorectal cancer is typically diagnosed after age 50, but in recent years the disease has been increasingly found in younger ...

Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...

A new research paper was published in Oncotarget's Volume 16 on January 20, 2025, titled "Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells." ...